Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma.
| Conditions: | Mesothelioma |
| Start Date: | |
| Phase: | Phase II |
| Status: | Approved for marketing |
| NCT ID: | NCT00040625 |
| Study Type: | Expanded Access |
| Intervention: | Drug: Pemetrexed|Drug: Cisplatin |
| Study Design: | |
| Results: | No Results Available |
| Sponsors: | Eli Lilly and Company |
| Ages: | Adult|Senior |
| Enrollment: | 0 |
| Funded By: | Industry |
| First Received: | July 2, 2002 |
| End Date: | |
| Last Updated: | March 14, 2007 |
| Last Verified: | March 1, 2007 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
